← Leaderboards
Bruce Dale Weintraub
University Of Maryland Baltimore
$12,555,738
Attributed
$16,323,323
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2006–21$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$16,173,323 · 14
FDA$150,000 · 1
By mechanism
R44$14,894,389 · 8
R43$969,226 · 5
R01$311,208 · 1
R21$148,500 · 1
Top collaborators
- Mariusz W Szkudlinski14 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- France Carrier$2,949,818
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogBioreactorsRecombinantsIn VivoIn VitroHormonesCommercializationSmall Business Innovation Research GrantGlycoproteinsChinese Hamster Ovary CellHormone AnalogReceptor BindingProductionGenerationsMalignant Neoplasm Of ThyroidAffinityAffectWomanRodentLeadTumorEndocrineDiagnosticDiagnostic Imaging
Grant awards (29)
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.$345,085
R44 · FY2021 · CA · contact PI
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle$727,601
R44 · FY2020 · HD · contact PI
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.$433,685
R44 · FY2020 · CA · contact PI
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility$942,701
R44 · FY2019 · HD · contact PI
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.$778,770
R44 · FY2019 · CA · contact PI
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle$733,166
R44 · FY2019 · HD · contact PI
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility$825,420
R44 · FY2018 · HD · contact PI
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.$285,070
R44 · FY2018 · CA · contact PI
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility$299,999
R44 · FY2017 · HD · contact PI
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle$138,880
R43 · FY2017 · HD · contact PI
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer$765,782
R44 · FY2015 · CA · contact PI
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer$825,054
R44 · FY2014 · CA · contact PI
Development of Superactive Analogs of FSH for Human Infertility$972,062
R44 · FY2013 · HD · contact PI
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer$283,958
R44 · FY2013 · CA · contact PI
Development of Superactive Analogs of FSH for Human Infertility$972,062
R44 · FY2012 · HD · contact PI
Novel High Affinity and Long-Acting Bovine FSH Analogs for Veterinary Superovulat$150,000
R43 · FY2012 · FD · contact PI
Development of Superactive Analogs of FSH for Human Infertility$972,062
R44 · FY2011 · HD · contact PI
Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer$910,851
R44 · FY2011 · DK · contact PI
Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer$829,058
R44 · FY2010 · DK · contact PI
Development of Superagonist Analogs of Recombinant Human TSH for Imaging and Ther$880,167
R44 · FY2009 · DK · contact PI
Development of Superagonist Analogs of Recombinant Human TSH for Imaging and Ther$894,568
R44 · FY2008 · DK · contact PI
Development of Superactive Analogs of Follice Stimulating Hormone (FSH)$616,035
R44 · FY2007 · DK · contact PI
Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer$239,423
R43 · FY2007 · DK · contact PI
Development of Superactive Analogs of FSH$601,233
R44 · FY2006 · DK · contact PI
Recombinant Human TSH Superagonists for Imaging of Thyroid Cancer$239,423
R43 · FY2006 · DK · contact PI
Development of Superagonist Analogs of Recombinant Human TSH$101,500
R43 · FY2006 · DK · contact PI
Development of Superactive Analogs of LH and FSH$100,000
R43 · FY2004 · DK
NOVEL VEGF SUPERAGONISTS/SUPERANTAGONISTS FOR DIABETES$148,500
R21 · FY2001 · DK
STRUCTURE/FUNCTION RELATIONSHIPS OF HUMAN THYROTROPIN$311,208
R01 · FY2000 · DK